Venous Malformations and Associated Syndromes: Diagnosis and Management

  • Chapter
  • First Online:
Vascular Anomalies

Abstract

Venous malformations are congenital low-flow vascular malformations. Venous malformations commonly present in the skin and superficial soft tissues; they can involve deeper structures. Venous malformations are associated with other vascular anomaly syndromes as well. Common presenting symptoms include swelling, pain, mass effect, and psychosocial stressors. Coagulopathy is observed with diffuse and multifocal lesions. Ultrasonography and magnetic resonance imaging are useful adjuncts for diagnosis and understanding extent and relationship to adjacent structures. Mainstays of therapy include expectant management, compression, pain control, sclerotherapy, and surgical resection. Multimodal and interdisciplinary care is crucial to provide comprehensive care to patients with venous malformations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Hassanein AH, Mulliken JB, Fishman SJ, Alomari AI, Zurakowski D, Greene AK. Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg. 2012;68(2):198–201.

    CAS  PubMed  Google Scholar 

  2. Masson P. Hemangioendotheliome vegetant intravasculaire. Anat Paris. 1923;93:517.

    Google Scholar 

  3. Kozakewich HPMJ. Histopathology of vascular malformations. In: Mulliken JB, Burrows P, Fishman SJ, editors. Mulliken and Young’s vascular anomalies: hemangiomas and malformations. 2nd ed. New York: Oxford University Press; 2013. p. 480–507.

    Google Scholar 

  4. Alomari AI, Spencer SA, Arnold RW, et al. Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity. J Pediatr Orthop. 2014;34(1):109–17.

    PubMed  Google Scholar 

  5. Boon LM, Mulliken JB, Enjolras O, Vikkula M. Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol. 2004;140(8):971–6.

    PubMed  Google Scholar 

  6. Limaye N, Wouters V, Uebelhoer M, et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet. 2009;41(1):118–24.

    CAS  PubMed  Google Scholar 

  7. Soblet J, Limaye N, Uebelhoer M, Boon LM, Vikkula M. Variable somatic TIE2 mutations in half of sporadic venous malformations. Mol Syndromol. 2013;4(4):179–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Natynki M, Kangas J, Miinalainen I, et al. Common and specific effects of TIE2 mutations causing venous malformations. Hum Mol Genet. 2015;24(22):6374–89.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Greene AK, Goss JA. Vascular anomalies: from a clinicohistologic to a genetic framework. Plast Reconstr Surg. 2018;141(5):709e–17e.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Vikkula M, Boon LM, Carraway KL 3rd, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 1996;87(7):1181–90.

    CAS  PubMed  Google Scholar 

  11. Vikkula M, Boon LM, Mulliken JB, Olsen BR. Molecular basis of vascular anomalies. Trends Cardiovasc Med. 1998;8(7):281–92.

    CAS  PubMed  Google Scholar 

  12. Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 1996;87(7):1171–80.

    CAS  PubMed  Google Scholar 

  13. Wouters V, Limaye N, Uebelhoer M, et al. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet. 2010;18(4):414–20.

    CAS  PubMed  Google Scholar 

  14. Brouillard P, Boon LM, Revencu N, et al. Genotypes and phenotypes of 162 families with a glomulin mutation. Mol Syndromol. 2013;4(4):157–64.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Boon LM, Brouillard P, Irrthum A, et al. A gene for inherited cutaneous venous anomalies (“glomangiomas”) localizes to chromosome 1p21-22. Am J Hum Genet. 1999;65(1):125–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Brouillard P, Boon LM, Mulliken JB, et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (“glomangiomas”). Am J Hum Genet. 2002;70(4):866–74.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Boon L, Vikkula M. Molecular genetics of vascular malformations. In: Mulliken J, Burrows P, Fishman S, editors. Mulliken and Youngs’ vascular anomalies: hemangiomas and malformations. 2nd ed. New York: Oxford University Press; 2013. p. 327–75.

    Google Scholar 

  18. Cotten A, Flipo RM, Herbaux B, Gougeon F, Lecomte-Houcke M, Chastanet P. Synovial haemangioma of the knee: a frequently misdiagnosed lesion. Skelet Radiol. 1995;24(4):257–61.

    CAS  Google Scholar 

  19. Devaney K, Vinh TN, Sweet DE. Synovial hemangioma: a report of 20 cases with differential diagnostic considerations. Hum Pathol. 1993;24(7):737–45.

    CAS  PubMed  Google Scholar 

  20. Spencer SA, Sorger J. Orthopedic issues in vascular anomalies. Semin Pediatr Surg. 2014;23(4):227–32.

    PubMed  Google Scholar 

  21. Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg. 2000;37(8):517–84.

    CAS  PubMed  Google Scholar 

  22. Fishman SJ, Fox VL. Visceral vascular anomalies. Gastrointest Endosc Clin N Am. 2001;11(4):813–34.. viii

    CAS  PubMed  Google Scholar 

  23. Fishman SJ, Burrows PE, Leichtner AM, Mulliken JB. Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities. J Pediatr Surg. 1998;33(7):1163–7.

    CAS  PubMed  Google Scholar 

  24. Kulungowski AM, Fox VL, Burrows PE, Alomari AI, Fishman SJ. Portomesenteric Venous Thrombosis Associated with Rectal Venous Malformation. J Pediatr Surg. 2010.(in press;45:1221.

    PubMed  Google Scholar 

  25. MacSween RM, Anthony PP, Scheuer PJ. Pathology of the liver. New York: Churchill Livingstone; 1987.

    Google Scholar 

  26. Fishman S. Truncal, visceral, and genital vascular malformations. In: Mulliken J, Burrows P, Fishman S, editors. Mulliken and Young's Vascular Anomalies: Hemangiomas and Malformations. 2nd ed. New York: Oxford University Press; 2013. p. 966–1016.

    Google Scholar 

  27. Jahn H, Nissen HM. Haemangioma of the urinary tract: review of the literature. Br J Urol. 1991;68(2):113–7.

    CAS  PubMed  Google Scholar 

  28. Greene AK, Rogers GF, Mulliken JB. Intraosseous “hemangiomas” are malformations and not tumors. Plast Reconstr Surg. 2007;119(6):1949–50; author reply 1950.

    CAS  PubMed  Google Scholar 

  29. Mounayer C, Wassef M, Enjolras O, Boukobza M, Mulliken JB. Facial “glomangiomas”: large facial venous malformations with glomus cells. J Am Acad Dermatol. 2001;45(2):239–45.

    CAS  PubMed  Google Scholar 

  30. Mallory SB, Enjolras O, Boon LM, et al. Congenital plaque-type glomuvenous malformations presenting in childhood. Arch Dermatol. 2006;142(7):892–6.

    PubMed  Google Scholar 

  31. Ardillon L, Lambert C, Eeckhoudt S, Boon LM, Hermans C. Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations. Blood Coagul Fibrinolysis. 2015;27(2):216–9.

    Google Scholar 

  32. Bean W. Blue rubber-bleb nevi of the skin and gastrointestinal tract. In: Vascular spiders and related lesions of the skin, vol. 1958. Springfield: Charles C Thomas. p. 17–185.

    Google Scholar 

  33. Gascoyen M. Case of naevus involving the parotid gland and causing suffocation. Trans Pathol Soc (Lond). 1860;11:267.

    Google Scholar 

  34. Fishman SJ, Smithers CJ, Folkman J, et al. Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding. Ann Surg. 2005;241(3):523–8.

    PubMed  PubMed Central  Google Scholar 

  35. Beluffi G, Romano P, Matteotti C, Minniti S, Ceffa F, Morbini P. Jejunal intussusception in a 10-year-old boy with blue rubber bleb nevus syndrome. Pediatr Radiol. 2004;34(9):742–5.

    PubMed  Google Scholar 

  36. Lee C, Debnath D, Whitburn T, Farrugia M, Gonzalez F. Synchronous multiple small bowel intussusceptions in an adult with blue rubber bleb naevus syndrome: report of a case and review of literature. World J Emerg Surg. 2008;3:3.

    PubMed  PubMed Central  Google Scholar 

  37. Fishman G, DeRowe A, Singhal V. Congenital internal and external jugular venous aneurysms in a child. Br J Plast Surg. 2004;57(2):165–7.

    PubMed  Google Scholar 

  38. Kulungowski AM, Fishman SJ. Management of combined vascular malformations. Clin Plast Surg. 2011;38(1):107–20.

    PubMed  Google Scholar 

  39. Reis J, Alomari AI, Trenor CC, et al. Pulmonary thromboembolic events in patients with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal/skeletal abnormalities and Klippel-Trénaunay syndrome. J Vasc Surg Venous Lymphat Disord. 2018;6(4):511–6.

    PubMed  Google Scholar 

  40. Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. J Am Acad Dermatol. 1997;36(2. Pt 1):219–25.

    CAS  PubMed  Google Scholar 

  41. Mazoyer E, Enjolras O, Bisdorff A, Perdu J, Wassef M, Drouet L. Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol. 2008;144(7):861–7.

    PubMed  Google Scholar 

  42. Adams D, Neufeld E. Coagulopathy and vascular malformations. In: Mulliken J, Burrows P, Fishman S, editors. Mulliken and Young’s vascular anomalies: hemangiomas and malformations. 2nd ed. New York: Oxford University Press; 2013. p. 637–44.

    Google Scholar 

  43. Rodríguez-Mañero M, Aguado L, Redondo P. Pulmonary arterial hypertension in patients with slow-flow vascular malformations. Arch Dermatol. 2010;146(12):1347–52.

    PubMed  Google Scholar 

  44. Nguyen JT, Koerper MA, Hess CP, et al. Aspirin therapy in venous malformation: a retrospective cohort study of benefits, side effects, and patient experiences. Pediatr Dermatol. 2014;31(5):556–60.

    PubMed  Google Scholar 

  45. Lee DF, Hung MC. All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle. 2007;6(24):3011–4.

    CAS  PubMed  Google Scholar 

  46. Erickson J, McAuliffe W, Blennerhassett L, Halbert A. Fibroadipose vascular anomaly treated with sirolimus: Successful outcome in two patients. Pediatr Dermatol. 2017;34(6):e317–20.

    PubMed  Google Scholar 

  47. Salloum R, Fox CE, Alvarez-Allende CR, et al. Response of blue rubber bleb nevus syndrome to Sirolimus treatment. Pediatr Blood Cancer. 2016;63(11):1911–4.

    CAS  PubMed  Google Scholar 

  48. Hammer J, Seront E, Duez S, et al. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study. Orphanet J Rare Dis. 2018;13(1):191.

    Google Scholar 

  49. Burrows P. Percutaneous treatment of slow-flow vascular malformations. In: Mulliken J, Burrows P, Fishman S, editors. Mulliken and Young’s vascular anomalies: hemangiomas and malformations. 2nd ed. New York: Oxford University Press; 2013. p. 661–709.

    Google Scholar 

  50. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol. 2004;15(5):431–45.

    PubMed  Google Scholar 

  51. Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139(11):1409–16.

    PubMed  Google Scholar 

  52. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg. 1999;104(1):1–11; discussion 12–15.

    CAS  PubMed  Google Scholar 

  53. Shaikh R, Alomari AI, Kerr CL, Miller P, Spencer SA. Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option. Pediatr Radiol. 2016;46(8):1179–86.

    PubMed  Google Scholar 

  54. Barranco-Pons R, Burrows PE, Landrigan-Ossar M, Trenor CC, Alomari AI. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures. AJR Am J Roentgenol. 2012;199(3):691–4.

    PubMed  Google Scholar 

  55. Uller W, El-Sobky S, Alomari AI, et al. Preoperative embolization of venous malformations using n-Butyl Cyanoacrylate. Vasc Endovasc Surg. 2018;52(4):269–74.

    Google Scholar 

  56. Tieu DD, Ghodke BV, Vo NJ, Perkins JA. Single-stage excision of localized head and neck venous malformations using preoperative glue embolization. Otolaryngol Head Neck Surg. 2013;148(4):678–84.

    PubMed  Google Scholar 

  57. Upton IIIJ. Vascular malformations of the extremities. In: Mulliken J, Burrows P, Fishman S, editors. Mulliken and Young’s vascular anomalies: hemangiomas and malformations. 2nd ed. New York: Oxford University Press; 2013. p. 903–65.

    Google Scholar 

  58. Borsellino A, Poggiani C, Alberti D, et al. Lower gastrointestinal bleeding in a newborn caused by isolated intestinal vascular malformation. Pediatr Radiol. 2003;33(1):41–3.

    PubMed  Google Scholar 

  59. Fishman SJ, Shamberger RC, Fox VL, Burrows PE. Endorectal pull-through abates gastrointestinal hemorrhage from colorectal venous malformations. J Pediatr Surg. 2000;35(6):982–4.

    CAS  PubMed  Google Scholar 

  60. Kulungowski AM, Schook CC, Alomari AI, Vogel AM, Mulliken JB, Fishman SJ. Vascular anomalies of the male genitalia. J Pediatr Surg. 2011;46(6):1214–21.

    PubMed  Google Scholar 

  61. Smithers CJ, Vogel AM, Kozakewich HP, et al. An injectable tissue-engineered embolus prevents luminal recanalization after vascular sclerotherapy. J Pediatr Surg. 2005;40(6):920–5.

    PubMed  Google Scholar 

  62. Kulungowski AM, Hassanein AH, Foster CC, Greene AK, Fishman SJ. Bevacizumab and interferon reduce venous recanalization following sclerotherapy. J Pediatr Surg. 2016;51(10):1670–3.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ann M. Kulungowski .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kulungowski, A.M., Patel, M.N., Fishman, S.J. (2020). Venous Malformations and Associated Syndromes: Diagnosis and Management. In: Trenor III, C., Adams, D. (eds) Vascular Anomalies. Springer, Cham. https://doi.org/10.1007/978-3-030-25624-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25624-1_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25622-7

  • Online ISBN: 978-3-030-25624-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Navigation